[PHARMA] YoY Annual (Unaudited) Result on 31-Dec-2016 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
YoY- -45.74%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 2,820,530 2,384,956 2,323,960 2,189,022 2,189,312 2,122,933 1,946,639 6.37%
PBT -191,865 70,220 73,064 72,017 112,722 125,580 92,997 -
Tax 42,418 -26,990 -17,977 -26,158 -28,138 -31,355 -36,236 -
NP -149,447 43,230 55,087 45,859 84,584 94,225 56,761 -
-
NP to SH -149,219 42,468 53,823 45,599 84,044 93,844 55,200 -
-
Tax Rate - 38.44% 24.60% 36.32% 24.96% 24.97% 38.96% -
Total Cost 2,969,977 2,341,726 2,268,873 2,143,163 2,104,728 2,028,708 1,889,878 7.82%
-
Net Worth 336,573 509,862 526,888 531,169 529,482 525,526 486,754 -5.96%
Dividend
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Div 22,177 41,621 49,314 41,457 77,674 72,486 41,477 -9.90%
Div Payout % 0.00% 98.01% 91.62% 90.92% 92.42% 77.24% 75.14% -
Equity
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Net Worth 336,573 509,862 526,888 531,169 529,482 525,526 486,754 -5.96%
NOSH 261,229 260,505 259,821 259,377 258,915 258,880 258,911 0.14%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -5.30% 1.81% 2.37% 2.09% 3.86% 4.44% 2.92% -
ROE -44.33% 8.33% 10.22% 8.58% 15.87% 17.86% 11.34% -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
RPS 1,081.04 916.82 895.38 844.83 845.57 820.05 751.85 6.23%
EPS -57.19 16.33 20.74 17.60 32.46 36.25 21.32 -
DPS 8.50 16.00 19.00 16.00 30.00 28.00 16.02 -10.01%
NAPS 1.29 1.96 2.03 2.05 2.045 2.03 1.88 -6.08%
Adjusted Per Share Value based on latest NOSH - 259,377
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
RPS 195.70 165.48 161.25 151.88 151.90 147.30 135.07 6.37%
EPS -10.35 2.95 3.73 3.16 5.83 6.51 3.83 -
DPS 1.54 2.89 3.42 2.88 5.39 5.03 2.88 -9.90%
NAPS 0.2335 0.3538 0.3656 0.3685 0.3674 0.3646 0.3377 -5.96%
Price Multiplier on Financial Quarter End Date
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Date 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 -
Price 2.06 2.78 4.60 5.30 6.36 4.58 4.45 -
P/RPS 0.19 0.30 0.51 0.63 0.75 0.56 0.59 -17.20%
P/EPS -3.60 17.03 22.18 30.12 19.59 12.63 20.87 -
EY -27.76 5.87 4.51 3.32 5.10 7.91 4.79 -
DY 4.13 5.76 4.13 3.02 4.72 6.11 3.60 2.31%
P/NAPS 1.60 1.42 2.27 2.59 3.11 2.26 2.37 -6.33%
Price Multiplier on Announcement Date
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Date 20/02/20 21/02/19 27/02/18 21/02/17 15/02/16 23/02/15 24/02/14 -
Price 2.04 2.76 4.04 5.12 6.19 5.28 4.29 -
P/RPS 0.19 0.30 0.45 0.61 0.73 0.64 0.57 -16.72%
P/EPS -3.57 16.91 19.48 29.09 19.07 14.57 20.12 -
EY -28.04 5.92 5.13 3.44 5.24 6.87 4.97 -
DY 4.17 5.80 4.70 3.13 4.85 5.30 3.73 1.87%
P/NAPS 1.58 1.41 1.99 2.50 3.03 2.60 2.28 -5.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment